Catalyst Wire Dossier Catalyst Wire Dossier

AVLAYAH

tividenofusp alfa-eknm · Denali Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AVLAYAH, covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: FDA Approved: AVLAYAH — Original Application (Denali Therapeutics Inc.)

See pricing